Could this pill stop Alzheimer's before it starts? new trial targets High-Risk gene carriers
Prevention
Not yet recruiting
This study tests an experimental drug, HT-4253, to see if it can lower the risk of developing Alzheimer's disease in people who carry the APOE4 gene and have early signs of brain changes. About 112 participants aged 50-75 will receive either the drug or a placebo for 48 weeks. Th…
Phase: PHASE2 • Sponsor: Halia Therapeutics, Inc. • Aim: Prevention
Last updated May 15, 2026 11:56 UTC